cilostazol
NDC 60505-2521, cilostazol, tablet, from Apotex Corp..
- Product NDC
- 60505-2521
- Status
- Listed
- Labeler
- Apotex Corp.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077030
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60505-2521 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CILOSTAZOL50 mg/1
Pharmacologic classes
Phosphodiesterase 3 Inhibitor [EPC]; Phosphodiesterase 3 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60505-2521-1 | 60505252101 | 60 TABLET in 1 BOTTLE (60505-2521-1) |
| 60505-2521-3 | 60505252103 | 30 TABLET in 1 BOTTLE (60505-2521-3) |
| 60505-2521-8 | 60505252108 | 1000 TABLET in 1 BOTTLE (60505-2521-8) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ceac1ae3-c343-28ca-c083-b748d21a15e6NADAC price for package 60505252101
GET /v1/drugs/nadac/60505252101
Use it
Look up 60505-2521 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60505-2521 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60505-2521. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.